Загрузка...
2172. Assessment of Cefepime Neurotoxicity in the FDA Adverse Reporting System
BACKGROUND: Cefepime is a fourth-generation cephalosporin antibiotic used for the treatment of neutropenic fever, pneumonia, and urinary tract infections. The safety of cefepime is now being questioned as it has recently been implicated as a possible cause for lesser known adverse effects, including...
Сохранить в:
| Опубликовано в: : | Open Forum Infect Dis |
|---|---|
| Главные авторы: | , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Oxford University Press
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6254527/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofy210.1828 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|